Is It Time to Buy Altria Stock?
Altria’s attempts to diversify have soured and its stock is lagging, but the company has pricing power and pays a solid dividend.
Altria’s attempts to diversify have soured and its stock is lagging, but the company has pricing power and pays a solid dividend.
Analysts see some magic in Disney stock as resorts and theme parks reopen and NBA resumes play.
Apple has recovered from the pandemic to hit a new high, and analysts are still bullish on the stock.
Analysts clear Boeing stock for takeoff as travel demand picks up.
AMD is optimistic about the future, particularly the data center business, even if analysts don’t see much upside for the stock.
Beyond Meat has taken advantage of expanding interest in vegan products as the COVID-19 pandemic reduced meat supplies, but competitor Impossible Foods has thrown down the gauntlet with a new direct-to-consumer website.
Government backing of Fannie Mae and Freddie Mac looks crucial as the pandemic impacts mortgage delinquencies.
As the country reopens for business Roku may be lagging because it’s a stay-at-home stock.
Facebook, under fire over President Trump’s posts, will label foreign state content. Do investors care?
Nvidia has been a star performer in a strong semiconductor industry and may have still more upside after its Mellanox acquisition.
Amarin is on hold as generic rivals seek to copy its potential blockbuster Vascepa.
Boeing rallies amid signals of confidence from a big hedge fund and a big aircraft leaser.
Lyft stock jumped this week after the ride-sharing company revised its outlook as riders slowly return.
Nike doesn’t shy away from difficult subjects, and the current protest movement is no exception.
Mark Zuckerberg won’t remove or add warning labels to posts by President Trump, and that may be an issue for some advertisers, users and employees.
AT&T adapts its advertising to troubled times, spending more on live news and targeting stay-at-home consumers online.
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
Amarin is going ahead with a big marketing campaign for potential COVID treatment Vascepa after a disruption caused by the pandemic.
A class-action lawsuit was filed against Lyft by a former driver in Washington, D.C., contending that the company is contributing to the spread of COVID-19 by its failure to provide paid time off for…
With most Disney businesses drastically affected by the COVID-19 pandemic, the questions of how and when various units will return to operation are vital for the company, its bottom line and its stock price.